U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757048) titled 'A Study of Treatment Patterns and Real-World Outcomes in IgA Nephropathy Patients in the United States' on Aug. 05.
Brief Summary: The aim of this study was to characterize real-world treatment patterns, including therapy sequences, escalation, and duration, and treatment outcomes in IgA nephropathy (IgAN) patients in the United States (US). The study used data which has detailed information on renal biopsy and laboratory data, linked with medical and pharmacy claims.
Study Start Date: March 12
Study Type: OBSERVATIONAL
Condition:
IGA Nephropathy
Recruitment Status: COMPLETED
Sponsor: Novartis Pharmaceuticals
Published by HT ...